Rebastinib (DCC-2036)

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
5 mg	3-5days	￥620.00	Visible after login	- +
10 mg	3-5days	￥1000.00	Visible after login	- +
25 mg	3-5days	￥1800.00	Visible after login	- +

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

5 mg

3-5days

￥620.00

Visible after login

- +

10 mg

3-5days

￥1000.00

Visible after login

- +

25 mg

3-5days

￥1800.00

Visible after login

- +

Product Overview

Product Name	Rebastinib (DCC-2036)
CAS	1020172-07-9
Formula	C30H28FN7O3
MW	553.59
Appearance	White to off-white powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Rebastinib (formerly also known as DCC-2036), a novel, potent and orally bioavailable small-molecule inhibitor of multiple tyrosine kinases with potential antineoplastic activity, is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50s of 0.8 nM and 4 nM. It also inhibits other kinases such as SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and has low activity towards c-Kit. DCC-2036 inhibits ABL1 through forcing the kinase domains into inhibitor-bound, inactive Type II conformations. In cellular assay, DCC-2036 inhibits the proliferation of Ba/F3 and K562 cells with IC50 values of 5.4nM and 5.5nM, respectively.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History